Keywords
Last Name
Institution

LI-YUAN YU-LEE

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Immunology, Allergy, Rheum
AddressOne Baylor Plaza- BCMD-535E
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pathology & Immunology
    DivisionImmunology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bilen MA, Pan T, Lee YC, Lin SC, Yu G, Pan J, Hawke DH, Pan BF, Vykoukal J, Gray K, Satcher RL, Gallick GE, Yu-Lee LY, Lin SH. Proteomics profiling of exosomes from primary mouse osteoblasts under proliferation versus mineralization conditions and characterization of their uptake into prostate cancer cells. J Proteome Res. 2017 Jul 04. PMID: 28675788.
      View in: PubMed
    2. Lockyer P, Mao H, Fan Q, Li L, Yu-Lee LY, Eissa NT, Patterson C, Xie L, Pi X. LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation. Arterioscler Thromb Vasc Biol. 2017 Jun 08. PMID: 28596374.
      View in: PubMed
    3. Lin SC, Lee YC, Yu G, Cheng CJ, Zhou X, Chu K, Murshed M, Le NT, Baseler L, Abe JI, Fujiwara K, deCrombrugghe B, Logothetis CJ, Gallick GE, Yu-Lee LY, Maity SN, Lin SH. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017 Jun 05; 41(5):467-480.e3. PMID: 28586644.
      View in: PubMed
    4. Zeng H, Ortiz A, Shen PF, Cheng CJ, Lee YC, Yu G, Lin SC, Creighton CJ, Yu-Lee LY, Lin SH. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017 Feb 07; 8(6):10145-10160. PMID: 28052036.
      View in: PubMed
    5. Cunningham CE, Li S, Vizeacoumar FS, Bhanumathy KK, Lee JS, Parameswaran S, Furber L, Abuhussein O, Paul JM, McDonald M, Templeton SD, Shukla H, El Zawily AM, Boyd F, Alli N, Mousseau DD, Geyer R, Bonham K, Anderson DH, Yan J, Yu-Lee LY, Weaver BA, Uppalapati M, Ruppin E, Sablina A, Freywald A, Vizeacoumar FJ. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016 Sep 20; 7(38):61544-61561. PMID: 27557495.
      View in: PubMed
    6. Weiderhold KN, Fadri-Moskwik M, Pan J, Nishino M, Chuang C, Deeraksa A, Lin SH, Yu-Lee LY. Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis. PLoS One. 2016; 11(4):e0153455. PMID: 27074040; PMCID: PMC4830538.
    7. Lee YC, Lin SC, Yu G, Cheng CJ, Liu B, Liu HC, Hawke DH, Parikh NU, Varkaris A, Corn P, Logothetis C, Satcher RL, Yu-Lee LY, Gallick GE, Lin SH. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59. PMID: 26530902.
      View in: PubMed
    8. Satcher RL, Pan T, Bilen MA, Li X, Lee YC, Ortiz A, Kowalczyk AP, Yu-Lee LY, Lin SH. Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. J Cell Sci. 2015 Dec 15; 128(24):4629-41. PMID: 26519476.
      View in: PubMed
    9. Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Mol Cell Proteomics. 2015 Mar; 14(3):471-83. PMID: 25527621; PMCID: PMC4349970.
    10. Ortiz A, Lee YC, Yu G, Liu HC, Lin SC, Bilen MA, Cho H, Yu-Lee LY, Lin SH. Angiomotin is a novel component of cadherin-11/?-catenin/p120 complex and is critical for cadherin-11-mediated cell migration. FASEB J. 2015 Mar; 29(3):1080-91. PMID: 25466890; PMCID: PMC4422367.
    11. Karlin KL, Mondal G, Hartman JK, Tyagi S, Kurley SJ, Bland CS, Hsu TY, Renwick A, Fang JE, Migliaccio I, Callaway C, Nair A, Dominguez-Vidana R, Nguyen DX, Osborne CK, Schiff R, Yu-Lee LY, Jung SY, Edwards DP, Hilsenbeck SG, Rosen JM, Zhang XH, Shaw CA, Couch FJ, Westbrook TF. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. Cell Rep. 2014 Nov 20; 9(4):1318-32. PMID: 25453754; PMCID: PMC4427000.
    12. Yu G, Lee YC, Cheng CJ, Wu CF, Song JH, Gallick GE, Yu-Lee LY, Kuang J, Lin SH. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. Mol Cancer Res. 2015 Feb; 13(2):348-57. PMID: 25189355; PMCID: PMC4336832.
    13. Lee PH, Puppi M, Schluns KS, Yu-Lee LY, Dong C, Lacorazza HD. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014 Jan 1; 192(1):178-88. PMID: 24259505; PMCID: PMC3872250.
    14. Chuang C, Pan J, Hawke DH, Lin SH, Yu-Lee LY. NudC deacetylation regulates mitotic progression. PLoS One. 2013; 8(9):e73841. PMID: 24069238; PMCID: PMC3777959.
    15. Lee YC, Bilen MA, Yu G, Lin SC, Huang CF, Ortiz A, Cho H, Song JH, Satcher RL, Kuang J, Gallick GE, Yu-Lee LY, Huang W, Lin SH. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis. Mol Cancer Res. 2013 Nov; 11(11):1401-11. PMID: 23913163; PMCID: PMC3834228.
    16. Wu CF, Liu S, Lee YC, Wang R, Sun S, Yin F, Bornmann WG, Yu-Lee LY, Gallick GE, Zhang W, Lin SH, Kuang J. RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene. 2014 May 1; 33(18):2385-94. PMID: 23708659; PMCID: PMC4026278.
    17. Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH. Targeting constitutively activated ?1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013 Apr; 11(4):405-17. PMID: 23339185; PMCID: PMC3631285.
    18. Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013 Jun 13; 32(24):2973-83. PMID: 22890325; PMCID: PMC3499666.
    19. Fadri-Moskwik M, Weiderhold KN, Deeraksa A, Chuang C, Pan J, Lin SH, Yu-Lee LY. Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J. 2012 Oct; 26(10):4057-67. PMID: 22751009; PMCID: PMC3448774.
    20. Chuang C, Yu-Lee LY. Identifying acetylated proteins in mitosis. Methods Mol Biol. 2012; 909:181-204. PMID: 22903717.
      View in: PubMed
    21. Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH. Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate. 2012 Feb; 72(3):291-300. PMID: 21681775; PMCID: PMC3179562.
    22. Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011 Aug 1; 71(15):5194-203. PMID: 21670081; PMCID: PMC3148283.
    23. Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res. 2010 Nov 1; 70(21):8812-21. PMID: 20978203; PMCID: PMC2970665.
    24. Chuang C, Lin SH, Huang F, Pan J, Josic D, Yu-Lee LY. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. J Proteome Res. 2010 Sep 3; 9(9):4554-64. PMID: 20812760; PMCID: PMC2935306.
    25. Huang CF, Lira C, Chu K, Bilen MA, Lee YC, Ye X, Kim SM, Ortiz A, Wu FL, Logothetis CJ, Yu-Lee LY, Lin SH. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010 Jun 1; 70(11):4580-9. PMID: 20484040; PMCID: PMC2923552.
    26. Lee YC, Cheng CJ, Huang M, Bilen MA, Ye X, Navone NM, Chu K, Kao HH, Yu-Lee LY, Wang Z, Lin SH. Androgen depletion up-regulates cadherin-11 expression in prostate cancer. J Pathol. 2010 May; 221(1):68-76. PMID: 20191612; PMCID: PMC2936767.
    27. Lee YC, Huang CF, Murshed M, Chu K, Araujo JC, Ye X, deCrombrugghe B, Yu-Lee LY, Gallick GE, Lin SH. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene. 2010 Jun 3; 29(22):3196-207. PMID: 20228840; PMCID: PMC2921959.
    28. Kurasawa Y, Yu-Lee LY. PICH and cotargeted Plk1 coordinately maintain prometaphase chromosome arm architecture. Mol Biol Cell. 2010 Apr 1; 21(7):1188-99. PMID: 20130082; PMCID: PMC2847523.
    29. Yamada M, Toba S, Takitoh T, Yoshida Y, Mori D, Nakamura T, Iwane AH, Yanagida T, Imai H, Yu-Lee LY, Schroer T, Wynshaw-Boris A, Hirotsune S. mNUDC is required for plus-end-directed transport of cytoplasmic dynein and dynactins by kinesin-1. EMBO J. 2010 Feb 3; 29(3):517-31. PMID: 20019668; PMCID: PMC2830693.
    30. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, Logothetis CJ, Lin SH. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008 Aug; 6(8):1259-67. PMID: 18708358; PMCID: PMC2643879.
    31. Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai MJ. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res. 2008 Jul 1; 68(13):5460-8. PMID: 18593949; PMCID: PMC2826835.
    32. Lin SH, Lee YC, Choueiri MB, Wen S, Mathew P, Ye X, Do KA, Navone NM, Kim J, Tu SM, Yu-Lee LY, Logothetis CJ. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res. 2008 Jun 15; 14(12):3729-36. PMID: 18559590; PMCID: PMC2562877.
    33. Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, Pasqualini R, Arap W, Navone NM, Tu SM, Hu M, Yu-Lee LY, Logothetis CJ. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 4; 27(39):5195-203. PMID: 18490922; PMCID: PMC2562662.
    34. Ishii S, Kurasawa Y, Wong J, Yu-Lee LY. Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4179-84. PMID: 18326024; PMCID: PMC2393771.
    35. Lee SH, Kunz J, Lin SH, Yu-Lee LY. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res. 2007 Nov 15; 67(22):11045-53. PMID: 18006851.
      View in: PubMed
    36. Chen N, Ye XC, Chu K, Navone NM, Sage EH, Yu-Lee LY, Logothetis CJ, Lin SH. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res. 2007 Jul 15; 67(14):6544-8. PMID: 17638862; PMCID: PMC2000837.
    37. Cheng CJ, Ye XC, Vakar-Lopez F, Kim J, Tu SM, Chen DT, Navone NM, Yu-Lee LY, Lin SH, Hu MC. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res. 2007 Jul; 5(7):675-84. PMID: 17634423; PMCID: PMC2000833.
    38. Choueiri MB, Tu SM, Yu-Lee LY, Lin SH. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006 Dec; 25(4):601-9. PMID: 17160554.
      View in: PubMed
    39. Nishino M, Kurasawa Y, Evans R, Lin SH, Brinkley BR, Yu-Lee LY. NudC is required for Plk1 targeting to the kinetochore and chromosome congression. Curr Biol. 2006 Jul 25; 16(14):1414-21. PMID: 16860740.
      View in: PubMed
    40. Lee SH, Nishino M, Mazumdar T, Garcia GE, Galfione M, Lee FL, Lee CL, Liang A, Kim J, Feng L, Eissa NT, Lin SH, Yu-Lee LY. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res. 2005 Sep 1; 65(17):7984-92. PMID: 16140971.
      View in: PubMed
    41. Vakar-Lopez F, Cheng CJ, Kim J, Shi GG, Troncoso P, Tu SM, Yu-Lee LY, Lin SH. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol. 2004 Jun; 203(2):688-95. PMID: 15141384.
      View in: PubMed
    42. Phan D, Cheng CJ, Galfione M, Vakar-Lopez F, Tunstead J, Thompson NE, Burgess RR, Najjar SM, Yu-Lee LY, Lin SH. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004 May 1; 64(9):3072-8. PMID: 15126343.
      View in: PubMed
    43. Lin SH, Nishino M, Luo W, Aumais JP, Galfione M, Kuang J, Yu-Lee LY. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein. Oncogene. 2004 Apr 1; 23(14):2499-506. PMID: 14676831.
      View in: PubMed
    44. Zhou T, Aumais JP, Liu X, Yu-Lee LY, Erikson RL. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell. 2003 Jul; 5(1):127-38. PMID: 12852857.
      View in: PubMed
    45. Aumais JP, Williams SN, Luo W, Nishino M, Caldwell KA, Caldwell GA, Lin SH, Yu-Lee LY. Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis. J Cell Sci. 2003 May 15; 116(Pt 10):1991-2003. PMID: 12679384.
      View in: PubMed
    46. Galfione M, Luo W, Kim J, Hawke D, Kobayashi R, Clapp C, Yu-Lee LY, Lin SH. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif. 2003 Apr; 28(2):252-8. PMID: 12699689.
      View in: PubMed
    47. Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, Lin SH. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Res. 2003 Jan 15; 63(2):386-93. PMID: 12543792.
      View in: PubMed
    48. Ramsay PL, Luo Z, Magdaleno SM, Whitbourne SK, Cao X, Park MS, Welty SE, Yu-Lee LY, DeMayo FJ. Transcriptional regulation of CCSP by interferon-gamma in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2003 Jan; 284(1):L108-18. PMID: 12388333.
      View in: PubMed
    49. Stewart MD, Choi Y, Johnson GA, Yu-Lee LY, Bazer FW, Spencer TE. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1. Biol Reprod. 2002 Feb; 66(2):393-400. PMID: 11804954.
      View in: PubMed
    50. Yu-Lee LY. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res. 2002; 57:435-55. PMID: 12017556.
      View in: PubMed
    51. Aumais JP, Tunstead JR, McNeil RS, Schaar BT, McConnell SK, Lin SH, Clark GD, Yu-Lee LY. NudC associates with Lis1 and the dynein motor at the leading pole of neurons. J Neurosci. 2001 Dec 15; 21(24):RC187. PMID: 11734602.
      View in: PubMed
    52. Frasor J, Park K, Byers M, Telleria C, Kitamura T, Yu-Lee LY, Djiane J, Park-Sarge OK, Gibori G. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. Mol Endocrinol. 2001 Dec; 15(12):2172-81. PMID: 11731618.
      View in: PubMed
    53. Book McAlexander M, Yu-Lee LY. Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene. Mol Cell Endocrinol. 2001 Nov 26; 184(1-2):135-41. PMID: 11694349.
      View in: PubMed
    54. Moreau N, Aumais JP, Prudhomme C, Morris SM, Yu-Lee LY. NUDC expression during amphibian development. Int J Dev Biol. 2001 Oct; 45(7):839-43. PMID: 11732844.
      View in: PubMed
    55. Johnson GA, Stewart MD, Gray CA, Choi Y, Burghardt RC, Yu-Lee LY, Bazer FW, Spencer TE. Effects of the estrous cycle, pregnancy, and interferon tau on 2',5'-oligoadenylate synthetase expression in the ovine uterus. Biol Reprod. 2001 May; 64(5):1392-9. PMID: 11319143.
      View in: PubMed
    56. Book McAlexander M, Yu-Lee L. Prolactin activation of IRF-1 transcription involves changes in histone acetylation. FEBS Lett. 2001 Jan 12; 488(1-2):91-4. PMID: 11163802.
      View in: PubMed
    57. Stewart MD, Stewart DM, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. Endocrinology. 2001 Jan; 142(1):98-107. PMID: 11145571.
      View in: PubMed
    58. Yu-Lee L. Stimulation of interferon regulatory factor-1 by prolactin. Lupus. 2001; 10(10):691-9. PMID: 11721695.
      View in: PubMed
    59. Stewart DM, Johnson GA, Vyhlidal CA, Burghardt RC, Safe SH, Yu-Lee LY, Bazer FW, Spencer TE. Interferon-? Activates Multiple Signal Transducer and Activator of Transcription Proteins and Has Complex Effects on Interferon-Responsive Gene Transcription in Ovine Endometrial Epithelial Cells* * This work was supported by NIH Grant HD-32534 (to F.W.B. and T.E.S.) and in part by NIH Grant P30-ES-09106. The publication costs of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Endocrinology. 2001 Jan 01; 142(1):98-107. PMID: 28201367.
      View in: PubMed
    60. Dogusan Z, Book ML, Verdood P, Yu-Lee LY, Hooghe-Peters EL. Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells. Eur Cytokine Netw. 2000 Sep; 11(3):435-42. PMID: 11022129.
      View in: PubMed
    61. McAveney KM, Book ML, Ling P, Chebath J, Yu-Lee L. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter. Mol Endocrinol. 2000 Feb; 14(2):295-306. PMID: 10674401.
      View in: PubMed
    62. Luo G, Yu-Lee L. Stat5b inhibits NFkappaB-mediated signaling. Mol Endocrinol. 2000 Jan; 14(1):114-23. PMID: 10628751.
      View in: PubMed
    63. Jabbour HN, Critchley HO, Yu-Lee LY, Boddy SC. Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle. J Clin Endocrinol Metab. 1999 Nov; 84(11):4260-5. PMID: 10566682.
      View in: PubMed
    64. Goenka S, Youn J, Dzurek LM, Schindler U, Yu-Lee LY, Boothby M. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. J Immunol. 1999 Nov 1; 163(9):4663-72. PMID: 10528163.
      View in: PubMed
    65. Herrington J, Rui L, Luo G, Yu-Lee LY, Carter-Su C. A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B. J Biol Chem. 1999 Feb 19; 274(8):5138-45. PMID: 9988763.
      View in: PubMed
    66. Yu-Lee L, Luo G, Moutoussamy S, Finidori J. Prolactin and growth hormone signal transduction in lymphohaemopoietic cells. Cell Mol Life Sci. 1998 Oct; 54(10):1067-75. PMID: 9817985.
      View in: PubMed
    67. Morris SM, Albrecht U, Reiner O, Eichele G, Yu-Lee LY. The lissencephaly gene product Lis1, a protein involved in neuronal migration, interacts with a nuclear movement protein, NudC. Curr Biol. 1998 May 7; 8(10):603-6. PMID: 9601647.
      View in: PubMed
    68. Yu-Lee LY, Luo G, Book ML, Morris SM. Lactogenic hormone signal transduction. Biol Reprod. 1998 Feb; 58(2):295-301. PMID: 9475379.
      View in: PubMed
    69. Morris SM, Yu-Lee LY. Expression of RNUDC, a potential nuclear movement protein, in mammalian cells: localization to the Golgi apparatus. Exp Cell Res. 1998 Jan 10; 238(1):23-32. PMID: 9457053.
      View in: PubMed
    70. Luo G, Yu-Lee L. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J Biol Chem. 1997 Oct 24; 272(43):26841-9. PMID: 9341115.
      View in: PubMed
    71. Wang Y, O'Neal KD, Yu-Lee L. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter. Mol Endocrinol. 1997 Aug; 11(9):1353-64. PMID: 9259325.
      View in: PubMed
    72. Smit LS, Vanderkuur JA, Stimage A, Han Y, Luo G, Yu-Lee LY, Schwartz J, Carter-Su C. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Endocrinology. 1997 Aug; 138(8):3426-34. PMID: 9231797.
      View in: PubMed
    73. Yu-Lee LY. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med. 1997 May; 215(1):35-52. PMID: 9142136.
      View in: PubMed
    74. Morris SM, Anaya P, Xiang X, Morris NR, May GS, Yu-Lee L. A prolactin-inducible T cell gene product is structurally similar to the Aspergillus nidulans nuclear movement protein NUDC. Mol Endocrinol. 1997 Feb; 11(2):229-36. PMID: 9013770.
      View in: PubMed
    75. McAveney KM, Gimble JM, Yu-Lee L. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. Endocrinology. 1996 Dec; 137(12):5723-6. PMID: 8940406.
      View in: PubMed
    76. Wang YF, Yu-Lee LY. Multiple stat complexes interact at the interferon regulatory factor-1 interferon-gamma activation sequence in prolactin-stimulated Nb2 T cells. Mol Cell Endocrinol. 1996 Jul 23; 121(1):19-28. PMID: 8865162.
      View in: PubMed
    77. O'Neal KD, Chari MV, Mcdonald CH, Cook RG, Yu-Lee LY, Morrisett JD, Shearer WT. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy. Biochem J. 1996 May 1; 315 ( Pt 3):833-44. PMID: 8645165; PMCID: PMC1217282.
    78. O'Neal KD, Yu-Lee LY, Shearer WT. The proline-rich motif is necessary but not sufficient for prolactin receptor signal transduction. Ann N Y Acad Sci. 1995 Sep 7; 766:282-4. PMID: 7486672.
      View in: PubMed
    79. Stevens AM, Wang YF, Sieger KA, Lu HF, Yu-Lee LY. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins. Mol Endocrinol. 1995 Apr; 9(4):513-25. PMID: 7659094.
      View in: PubMed
    80. Axtell SM, Truong TM, O'Neal KD, Yu-Lee LY. Characterization of a prolactin-inducible gene, clone 15, in T cells. Mol Endocrinol. 1995 Mar; 9(3):312-8. PMID: 7776977.
      View in: PubMed
    81. Wilson TM, Yu-Lee LY, Kelley MR. Coordinate gene expression of luteinizing hormone-releasing hormone (LHRH) and the LHRH-receptor after prolactin stimulation in the rat Nb2 T-cell line: implications for a role in immunomodulation and cell cycle gene expression. Mol Endocrinol. 1995 Jan; 9(1):44-53. PMID: 7760850.
      View in: PubMed
    82. O'Neal KD, Yu-Lee LY. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J Biol Chem. 1994 Oct 21; 269(42):26076-82. PMID: 7929319.
      View in: PubMed
    83. Horseman ND, Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev. 1994 Oct; 15(5):627-49. PMID: 7843070.
      View in: PubMed
    84. Snyder JG, Dinh Q, Morrison SL, Padlan EA, Mitchell M, Yu-Lee LY, Marcus DM. Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies. J Immunol. 1994 Aug 1; 153(3):1161-70. PMID: 7913110.
      View in: PubMed
    85. Stevens AM, Yu-Lee LY. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol. 1994 Mar; 8(3):345-55. PMID: 8015552.
      View in: PubMed
    86. O'Neal KD, Yu-Lee LY. The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily. Lymphokine Cytokine Res. 1993 Oct; 12(5):309-12. PMID: 8260540.
      View in: PubMed
    87. Stevens AM, Yu-Lee LY. The transcription factor interferon regulatory factor-1 is expressed during both early G1 and the G1/S transition in the prolactin-induced lymphocyte cell cycle. Mol Endocrinol. 1992 Dec; 6(12):2236-43. PMID: 1491701.
      View in: PubMed
    88. Weng NP, Yu-Lee LY, Sanz I, Patten BM, Marcus DM. Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J Immunol. 1992 Oct 1; 149(7):2518-29. PMID: 1527391.
      View in: PubMed
    89. O'Neal KD, Montgomery DW, Truong TM, Yu-Lee LY. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol. 1992 Sep; 87(1-3):R19-23. PMID: 1359980.
      View in: PubMed
    90. Schwarz LA, Stevens AM, Hrachovy JA, Yu-Lee LY. Interferon regulatory factor-1 is inducible by prolactin, interleukin-2 and concanavalin A in T cells. Mol Cell Endocrinol. 1992 Jul; 86(1-2):103-10. PMID: 1324854.
      View in: PubMed
    91. Weng NP, Snyder JG, Yu-Lee LY, Marcus DM. Polymorphism of human immunoglobulin VH4 germ-line genes. Eur J Immunol. 1992 Apr; 22(4):1075-82. PMID: 1348029.
      View in: PubMed
    92. O'Neal KD, Schwarz LA, Yu-Lee LY. Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol. 1991 Dec; 82(2-3):127-35. PMID: 1794604.
      View in: PubMed
    93. Snyder JG, Weng N, Yu-Lee LY, Marcus DM. Heavy and light chain sequences of four monoclonal antibodies that bind galactosylgloboside (GalGb4). Eur J Immunol. 1990 Dec; 20(12):2673-7. PMID: 2125273.
      View in: PubMed
    94. Yu-Lee LY, Hrachovy JA, Stevens AM, Schwarz LA. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol. 1990 Jun; 10(6):3087-94. PMID: 2342469; PMCID: PMC360673.
    95. Yu-Lee LY. Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol. 1990 Jan 2; 68(1):21-8. PMID: 2406173.
      View in: PubMed
    96. Yu-Lee LY, Stevens AM, Hrachovy JA, Schwarz LA. Prolactin-mediated regulation of gene transcription in lymphocytes. Ann N Y Acad Sci. 1990; 594:146-55. PMID: 2378484.
      View in: PubMed
    97. Yu-Lee LY, Rosen JM. A transfected alpha-casein minigene bypasses posttranscriptional control by hormones, but retains cell-substratum regulation in mammary epithelial cells. Mol Endocrinol. 1988 May; 2(5):431-43. PMID: 2458523.
      View in: PubMed
    98. Yu-Lee LY, Richter-Mann L, Couch CH, Stewart AF, Mackinlay AG, Rosen JM. Evolution of the casein multigene family: conserved sequences in the 5' flanking and exon regions. Nucleic Acids Res. 1986 Feb 25; 14(4):1883-902. PMID: 3952000; PMCID: PMC339580.
    99. Rosen JM, Rodgers JR, Couch CH, Bisbee CA, David-Inouye Y, Campbell SM, Yu-Lee LY. Multihormonal regulation of milk protein gene expression. Ann N Y Acad Sci. 1986; 478:63-76. PMID: 3541754.
      View in: PubMed
    100. Rosen JM, Jones WK, Rodgers JR, Compton JG, Bisbee CA, David-Inouye Y, Yu-Lee LY. Regulatory sequences involved in the hormonal control of casein gene expression. Ann N Y Acad Sci. 1986; 464:87-99. PMID: 3014951.
      View in: PubMed
    101. Jones WK, Yu-Lee LY, Clift SM, Brown TL, Rosen JM. The rat casein multigene family. Fine structure and evolution of the beta-casein gene. J Biol Chem. 1985 Jun 10; 260(11):7042-50. PMID: 3997858.
      View in: PubMed
    102. Johnson ML, Levy J, Supowit SC, Yu-Lee LY, Rosen JM. Tissue- and cell-specific casein gene expression. II. Relationship to site-specific DNA methylation. J Biol Chem. 1983 Sep 10; 258(17):10805-11. PMID: 6411721.
      View in: PubMed
    103. Yu-Lee LY, Rosen JM. The rat casein multigene family. I. Fine structure of the gamma-casein gene. J Biol Chem. 1983 Sep 10; 258(17):10794-804. PMID: 6309815.
      View in: PubMed
    YU-LEE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _